Scientific Programme

Workshop

Social

Call for Papers

Location

Register Free

Scientific Programme

Thursday June 20

8.45 Registration and networking
Chairman: Dr Robert Scoffin
9.15 Chairman’s introduction
9.30 Field points and structure based drug design
Dr Gianni Chessari, Director, Astex Pharmaceuticals
10.00 Upcoming features and future horizons
Dr Mark Mackey, Chief Scientific Officer, Cresset
10.30 Morning coffee and networking
Chairman: Dr Mark Mackey
11.00 Application of Forge and Spark to develop new drug candidates from lead compounds derived from network pharmacology models
Dr Ben Allen, Research Scientist, e-Therapeutics
11.30 Vinyl sulfone-based peptidomimetics as anti-trypanosomal agents
Dr Andrew Knox, Research Fellow, Trinity College Dublin
12.00 New drugs from old compounds
Dr Robert Scoffin, Chief Executive Officer, Cresset
12.30 Lunch and networking
Chairman: Dr Robert Scoffin
13.40 How to convince your medicinal chemist – from 3D-QSAR to scaffold hopping
Dr Daniel Kuhn, Global Computational Chemistry, Merck Serono
14.10 Computational approaches in fragment based drug discovery
Dr Ian Wall, Computational Chemist, GlaxoSmithKline
14.40 The trend to outsource computational chemistry
Dr Martin Slater, Director of Consulting, Cresset
15.05 Afternoon tea and networking
15.30 Conformational sampling tools
María José Ojeda Montes, Universitat Rovira i Virgili
15.45 Crystals, coformers and Cresset – adventures on the high C’s
Dr Peter Hunt, Senior Research Investigator, Novartis
16.15 Kinetics versus thermodynamids – insight into protein function
Dr Andy Vinter, Founder and Chairman, Cresset
16.40 Chairman’s closing remarks
17.00 Close

The programme is subject to change.